Oncology Data Advisor

Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS

Informações:

Synopsis

Assessing Risk of Myelosuppression With PARP Inhibitors in Prostate Cancer: Karan Jatwani, MBBS by i3 Health